The TRIPS Agreement is an agreement on minimum standards that allows members to guarantee, if they so wish, broader protection of intellectual property. Members are free to determine the appropriate method for implementing the provisions of the Agreement in their own legal and practical order. However, TRIPS also contains provisions that provide countries with a degree of flexibility and sufficient space to respond to their own patent and intangible asset systems and development needs. This means that countries have a certain degree of freedom to change their rules and that there are different options for formulating their national legislation to ensure a fair balance between the objective of encouraging the future invention of new medicines and the objective of affordable access to existing medicines. Its inclusion was the culmination of an intensive lobbying program by the United States, supported by the European Union, Japan and other developed countries. Unilateral economic support campaigns under the Generalized System of Preferences and coercion under Section 301 of the Trade Act have played an important role in suppressing competing political positions favoured by developing countries such as Brazil, but also Thailand, India and the Caribbean Basin countries. .